CN104480091A - Method for highly purifying kallikein and drug composition containing kallikein - Google Patents

Method for highly purifying kallikein and drug composition containing kallikein Download PDF

Info

Publication number
CN104480091A
CN104480091A CN201410807821.6A CN201410807821A CN104480091A CN 104480091 A CN104480091 A CN 104480091A CN 201410807821 A CN201410807821 A CN 201410807821A CN 104480091 A CN104480091 A CN 104480091A
Authority
CN
China
Prior art keywords
pancreokinin
proenzyme
acetone
buffer solution
acetate buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410807821.6A
Other languages
Chinese (zh)
Inventor
刘冠男
林晓磊
孙延年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO KANGYUAN PHARMACEUTICAL CO Ltd
Original Assignee
QINGDAO KANGYUAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO KANGYUAN PHARMACEUTICAL CO Ltd filed Critical QINGDAO KANGYUAN PHARMACEUTICAL CO Ltd
Priority to CN201410807821.6A priority Critical patent/CN104480091A/en
Publication of CN104480091A publication Critical patent/CN104480091A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6445Kallikreins (3.4.21.34; 3.4.21.35)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21034Plasma kallikrein (3.4.21.34)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21035Tissue kallikrein (3.4.21.35)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a method for highly purifying kallikein and a drug composition containing kallikein. According to the technical scheme, pig pancreas taken as a raw material is extracted and settled to prepare acetone powder, extraction of acetic acid and acetone precipitation are flexibly used, conventional and modern combined protein purification technologies such as ether degreasing and dewatering, synergic impurity removal bysodium chloride, ammonium hydroxide and acetone, ion exchange resin DEAE (diethylaminoethyl)-agarose fast gel sequential elution and the like are adopted for highly purifying kallikein. The method and the drug composition have characteristics of short production cycle, good chemical and thermal stability and low cost, and are very suitable for large-scale production.

Description

A kind of method of highly purified pancreokinin proenzyme and the pharmaceutical composition containing pancreokinin proenzyme
Technical field
The present invention relates to biological technical field, specifically be that raw material extracts with pig pancreas, after precipitation pig pancreas makes acetone powder, to apply in a flexible way acetic acid extraction, acetone precipitation, ether defatting dewaters, sodium chloride-ammonia, acetone work in coordination with removal of impurities, the Protein purification techniques that the tradition and modernities such as the fast glue stepwise elution of ion exchange resin DEAE-agarose combine, prepares pancreokinin proenzyme.
Background technology
Pancreokinin proenzyme (kallikein) is the natural Enzymes medicine that separation and purification is obtained from Pancreas Sus domestica, clinically also known as kallidinogenase, have and unfold capillary vessel and arteriolar effect, be commonly used to clinically treat hyperlipidemia, prevent and treat the various diseases such as fatty liver, atherosclerosis, hypertension, stenocardia, its exploitation has important medical science and social value.In China, pancreokinin proenzyme is produced also exists very large development space.
The technique of traditional purifying pancreokinin proenzyme due to complex process, cost higher; Ion exchange chromatography is the most common method of applicable pancreokinin proenzyme suitability for industrialized production at present; But usually need to adopt multiple import Ion Exchange Medium to carry out purifying to pancreokinin proenzyme, not only complex operation, and make the rate of recovery very low because of repeatedly upper prop, for the method for the people such as the Zhou Zumeng that most is with practical value, by under pH7.0, pH5.0, pH6.7 condition, successively by DEAE-Cellulose, DEAE-Sepharosecl-6B on gained sample, obtain the pancreokinin proenzyme of about specific activity 1500u/mg, yield is 40%.In addition, mostly adopt anionresin in the world at present, in conjunction with cationic exchange, finally add a step gel permeation chromatography, and the wash-out of pancreokinin proenzyme all adopts the mode changing pH in ion exchange process, due to the shock absorption of buffered soln, pH in post is made to change slowly, cycle stretch-out, at substantial damping fluid, with the purge process of French Graham S.Bailey, although after three step purifying, pancreokinin proenzyme specific activity is up to 1254u/mg, but yield only has 28.4%; Next has employing ion exchange chromatography to combine with affinity chromatography or hydrophobic chromatography, step is more, and purification cycle is longer and with high costs, for the purge process of Britain Talal S.EI.Thaher, although yield reaches 87%, pancreokinin proenzyme specific activity only has 156.3u/mg; Again, a kind of Ion Exchange Medium is adopted to want the pancreokinin proenzyme just being obtained high purity and high yield by purifying to be almost impossible mission, utilize Amberlite-CG50 mono-step separation and purification pancreokinin proenzyme from pancreatin with Li Lihuan etc., but its specific activity and yield only has 107.4u/mg and 12.1% respectively.
And the present invention is apply in a flexible way acetic acid extraction, acetone precipitation, ether defatting dewaters, sodium chloride-ammonia, acetone work in coordination with removal of impurities, the Protein purification techniques that the tradition and modernities such as the fast glue stepwise elution of ion exchange resin DEAE-agarose combine, the fast glue of DEAE-agarose is used to have high flow rate, high carrying capacity, effectively can shorten the production cycle, and to chemistry and Heat stability is good, the yield of product maintains the leading position in similar technique; And the method for pancreokinin proenzyme stepwise elution, although international highest standard can not be reached, still exceed the requirement of clinical application, be applicable to suitability for industrialized production.
Summary of the invention
The object of the invention is the highly purified pancreokinin proenzyme extracted from qualified Pancreas Sus domestica.
Technical scheme of the present invention is: be that raw material extracts with pig pancreas, after precipitation pig pancreas makes acetone powder, to apply in a flexible way acetic acid extraction, acetone precipitation, ether defatting dewaters, sodium chloride-ammonia, acetone work in coordination with removal of impurities, the Protein purification techniques that the tradition and modernities such as the fast glue stepwise elution of ion exchange resin DEAE-agarose combine, highly purified pancreokinin proenzyme.The present invention has with short production cycle, to chemistry and Heat stability is good, feature that cost is low, is highly suitable for the large production of mass-producing.Comprise the steps:
(1) acetic acid extraction: after Pancreas Sus domestica is made acetone powder, adds acetum and stirs extraction, centrifugal, obtains supernatant liquor;
(2) acetone precipitation: collect supernatant liquor, add acetone precipitation.Precipitation acetone, ether defatting, dehydration, dry, obtain pancreokinin proenzyme crude product;
(3) sodium chloride-ammonia, acetone work in coordination with removal of impurities: dissolved by crude product sodium chloride solution, adjust PH with ammoniacal liquor, be uniformly mixed, and filter, obtain filtrate; Acetone precipitation is added by filtrate.Precipitation acetone, washed with diethylether, dry, obtain product in the middle of pancreokinin proenzyme;
(4) ion exchange chromatography: product in the middle of pancreokinin proenzyme are dissolved in 0.0005 ~ 0.0015mol/L acetate buffer solution (pH4.5) of 18 ~ 22 times amount, centrifugal, obtain supernatant liquor; Get supernatant liquor, by the fast glue post absorption of DEAE-agarose in the volume ratio of 1:8 ~ 12, after adsorption equilibrium, baseline is eluted to the 0.01mol/L acetate buffer solution containing 0.15 ~ 0.25mol/L sodium-chlor, again with the 0.01mol/L acetate buffer solution wash-out containing 0.25 ~ 0.45mol/L sodium-chlor, collect elutriant; By elutriant dialysis desalting, freeze-drying, obtains pancreokinin proenzyme fine work.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1
Described be that raw material extracts with pig pancreas, after precipitation pig pancreas makes acetone powder, to apply in a flexible way acetic acid extraction, acetone precipitation, ether defatting dewaters, sodium chloride-ammonia, acetone work in coordination with removal of impurities, the Protein purification techniques that the tradition and modernities such as the fast glue stepwise elution of ion exchange resin DEAE-agarose combine, prepare pancreokinin proenzyme, comprise the steps:
(1) acetic acid extraction: after Pancreas Sus domestica 10Kg is made acetone powder, add the acetum of 30 times amount, stirs and extracts, centrifugal, obtains supernatant liquor 29.8L.
(2) acetone precipitation: collect supernatant liquor, add acetone precipitation.Precipitation acetone, ether defatting, dehydration, dry, obtain pancreokinin proenzyme crude product 93g.
(3) sodium chloride-ammonia, acetone work in coordination with removal of impurities: dissolved by crude product 50 times amount sodium chloride solutions, adjust PH, be uniformly mixed with ammoniacal liquor, filter, obtain filtrate; , add acetone precipitation.Precipitation acetone, washed with diethylether, dry, obtain product 60g in the middle of pancreokinin proenzyme.
(4) ion exchange chromatography: product in the middle of pancreokinin proenzyme are dissolved in the 0.001mol/L acetate buffer solution (pH4.5) of 20 times amount, centrifugal, obtain supernatant liquor; Get supernatant liquor, by the fast glue post absorption of DEAE-agarose in the volume ratio of 1:10, after adsorption equilibrium, be eluted to baseline with the 0.01mol/L acetate buffer solution containing 0.2mol/L sodium-chlor, again with the 0.01mol/L acetate buffer solution wash-out containing 0.35mol/L sodium-chlor, collect elutriant; By elutriant dialysis desalting, freeze-drying, obtains pancreokinin proenzyme fine work 42g.
Embodiment 2
Pancreatic Kininogenase 6000 unit prepared by embodiment 1, pregelatinized Starch 21.7g puts in mixing machine, stir 5 minutes, add dextrin 32.5g again, Icing Sugar 20.1g, EDTA-2Na 0.162g, sodium starch glycolate 1.23g is in mixing machine, stir after 20 minutes and the tackiness agent prepared in advance (is got L-hydroxypropylcellulose 2.0g to add 75% ethanol 20ml and make dissolving, obtain) and magnesium stearate lubricant 0.0031g, slowly add equably in mixing machine and stir, formed to particle, put into nodulizer to granulate, intermediate is checked, qualified rear tabletting machine makes 1000, label is enteric coated after the assay was approved.
The above is only preferred embodiment of the present invention, and be not restriction the present invention being made to other form, any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equivalent variations.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.

Claims (5)

1. the method for highly purified pancreokinin proenzyme and the pharmaceutical composition containing pancreokinin proenzyme, it is characterized in that, the method comprises the steps:
(1) acetic acid extraction: after Pancreas Sus domestica is made acetone powder, adds acetum and stirs extraction, centrifugal, obtains supernatant liquor;
(2) acetone precipitation: collect supernatant liquor, add acetone precipitation;
Precipitation acetone, ether defatting, dehydration, dry, obtain pancreokinin proenzyme crude product;
(3) sodium chloride-ammonia, acetone work in coordination with removal of impurities: dissolved by crude product sodium chloride solution, adjust PH with ammoniacal liquor, be uniformly mixed, and filter, obtain filtrate; Acetone precipitation is added by filtrate;
Precipitation acetone, washed with diethylether, dry, obtain product in the middle of pancreokinin proenzyme;
(4) ion exchange chromatography: product in the middle of pancreokinin proenzyme are dissolved in acetate buffer solution, centrifugal, obtain supernatant liquor; Get supernatant liquor, the fast glue post absorption of upper DEAE-agarose, after adsorption equilibrium, is eluted to baseline with the acetate buffer solution of sodium chloride-containing, then uses the acetate buffer solution wash-out of sodium chloride-containing, collect elutriant; By elutriant dialysis desalting, freeze-drying, obtains pancreokinin proenzyme fine work.
2. method according to claim 1, is characterized in that: in step (4), and in the middle of pancreokinin proenzyme, the ratio of product and acetum is: 1Kg:18 ~ 22L, the concentration of acetum is: 0.0005 ~ 0.0015mol/L, and pH value is 4.5.
3. method according to claim 1, is characterized in that: in step (4), and the acetate buffer solution being eluted to the sodium chloride-containing of baseline is the 0.01mol/L acetate buffer solution containing 0.15 ~ 0.25mol/L sodium-chlor; The acetate buffer solution of the sodium chloride-containing of second time wash-out is the 0.01mol/L acetate buffer solution containing 0.25 ~ 0.45mol/L sodium-chlor; .
4. method according to claim 1, is characterized in that: with the absorption of novel anion-exchange column in step (4), Ion Exchange Medium used is the fast glue of DEAE-agarose, and the volume ratio of the fast glue of DEAE-agarose and supernatant liquor is: 8 ~ 12:1.
5. a pharmaceutical composition, its pancreokinin proenzyme prepared containing with good grounds claim 1-4 as activeconstituents, also containing pregelatinized Starch, dextrin, Icing Sugar, L-hydroxypropylcellulose, sodium starch glycolate, Magnesium Stearate, EDTA-2Na, 75% ethanol.
CN201410807821.6A 2014-12-23 2014-12-23 Method for highly purifying kallikein and drug composition containing kallikein Pending CN104480091A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410807821.6A CN104480091A (en) 2014-12-23 2014-12-23 Method for highly purifying kallikein and drug composition containing kallikein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410807821.6A CN104480091A (en) 2014-12-23 2014-12-23 Method for highly purifying kallikein and drug composition containing kallikein

Publications (1)

Publication Number Publication Date
CN104480091A true CN104480091A (en) 2015-04-01

Family

ID=52754699

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410807821.6A Pending CN104480091A (en) 2014-12-23 2014-12-23 Method for highly purifying kallikein and drug composition containing kallikein

Country Status (1)

Country Link
CN (1) CN104480091A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105385670A (en) * 2015-11-24 2016-03-09 青岛康原药业有限公司 Method for highly purifying kallidin zymogen and drug composition improving stability of kallidin zymogen
CN105400758A (en) * 2015-11-26 2016-03-16 青岛康原药业有限公司 Method for purifying pancreatic kininogenase through synergism of sodium chloride-ammonia water and acetone and medicine composition for improving stability of pancreatic kininogenase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103725664A (en) * 2013-11-28 2014-04-16 青岛康原药业有限公司 Method for highly purifying kallikrein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103725664A (en) * 2013-11-28 2014-04-16 青岛康原药业有限公司 Method for highly purifying kallikrein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MARIUS LEMON ET AL: "The Isolation and Properties of Pig Submandibular Kallikrein", 《BIOCHEM. J.》 *
MARTIN ZUBER AND EDGAR SACHE: "Isolation and Characterization of Porcine Pancreatic Kallikrein", 《B I O C H E M I S T R Y》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105385670A (en) * 2015-11-24 2016-03-09 青岛康原药业有限公司 Method for highly purifying kallidin zymogen and drug composition improving stability of kallidin zymogen
CN105400758A (en) * 2015-11-26 2016-03-16 青岛康原药业有限公司 Method for purifying pancreatic kininogenase through synergism of sodium chloride-ammonia water and acetone and medicine composition for improving stability of pancreatic kininogenase

Similar Documents

Publication Publication Date Title
CN103725664B (en) A kind of method of highly purified kallikrein
US10214552B2 (en) Method for purifying beta-nicotinamide mononucleotide
Reeves et al. Calcium phosphate sequestering phosphopeptide from casein
CN102775523B (en) Process for preparing high-purity low-molecular heparin sodium
CN103409484B (en) Preparation method of superhigh malt syrup
Clonis et al. Novel cationic triazine dyes for protein purification
CN108530561A (en) A method of it is produced from heparin and extracts high-purity sulphuric acid heparan in waste
CN104480091A (en) Method for highly purifying kallikein and drug composition containing kallikein
CN103740686B (en) A kind of method with Extraction of acetic acid kallikrein
CN105385670A (en) Method for highly purifying kallidin zymogen and drug composition improving stability of kallidin zymogen
CN103667223B (en) A kind of method of sodium chloride-ammoniacal liquor, the collaborative purifying kallikrein of acetone
CN105624134B (en) The preparation method of restricted fibrin ferment
CN101914511B (en) Method for preparing high-purity pancreatic kininogenase
CN106967186B (en) A method of extracting heparin-like compound from air bladder
CN103936846B (en) A kind of purification process of protamine sulfate
RU2186849C2 (en) Method of purification of thrombin-like protease from snake venom
CN102335201A (en) Extract method of asteroid saponins
US4027012A (en) Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained
CN104531647A (en) Method for purifying pancreatic kininogenase by using synergism of sodium chloride-ammonia water and acetone and pharmaceutical composition containing pancreatic kininogenase
CN101073666B (en) Method for producing kallidin proenzyme raw-material medicine
CN104513816A (en) Method for extracting kallikein through acetic acid and medicine composition containing kallikein
CN109652398B (en) Preparation method of coagulation factor X activator RVV-X and prepared RVV-X
CN103130916A (en) Novel technology for extracting high purity heparin sodium from intestinal mucosa
CN101544968A (en) Industrial production method of earthworm fibrinolytic enzyme directly extracted by utilizing ion exchange resin
CN104558251A (en) Preparation method of heparin sodium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150401